Llwytho...
Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy
Arsenic trioxide (ATO)-based consolidation chemotherapy can be effective in patients with high-risk acute promyelocytic leukemia (APL) and might reduce anthracycline-related toxicity. We report a retrospective analysis of 63 patients with APL given 1 cycle of ATO-based consolidation chemotherapy. Th...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Prif Awduron: | , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4409502/ https://ncbi.nlm.nih.gov/pubmed/25499624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.11.001 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|